• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Relationship Between Functional Dyspepsia, PPI Therapy, and the Gastric Microbiome.

作者信息

Jagdish Balaji R, Kilgore William R

机构信息

Kansas City University of Medicine and Biosciences, Kansas City, MO.

Ascension Via Christi, Wichita, KS.

出版信息

Kans J Med. 2021 May 21;14(2):136-140. doi: 10.17161/kjm.vol1414831. eCollection 2021.

DOI:10.17161/kjm.vol1414831
PMID:34084274
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8158412/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dab/8158412/99c7e62bd9b6/14-136f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dab/8158412/99c7e62bd9b6/14-136f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dab/8158412/99c7e62bd9b6/14-136f1.jpg

相似文献

1
The Relationship Between Functional Dyspepsia, PPI Therapy, and the Gastric Microbiome.功能性消化不良、质子泵抑制剂治疗与胃微生物群之间的关系
Kans J Med. 2021 May 21;14(2):136-140. doi: 10.17161/kjm.vol1414831. eCollection 2021.
2
Effects of Proton Pump Inhibitors on the Gastric Mucosa-Associated Microbiota in Dyspeptic Patients.质子泵抑制剂对消化不良患者胃黏膜相关微生物群的影响。
Appl Environ Microbiol. 2016 Oct 27;82(22):6633-6644. doi: 10.1128/AEM.01437-16. Print 2016 Nov 15.
3
Is administration of proton pump inhibitors in functional dyspepsia worth the risk of developing gastric cancer: a Markov model to bridge the gap between scientific evidence and clinical practice.质子泵抑制剂在功能性消化不良中的应用是否值得罹患胃癌的风险：一种弥合科学证据与临床实践差距的马尔可夫模型。
BMJ Open. 2020 Feb 12;10(2):e031091. doi: 10.1136/bmjopen-2019-031091.
4
Proton pump inhibitors: effective first-line treatment for management of dyspepsia.质子泵抑制剂：消化不良管理的有效一线治疗方法。
Dig Dis Sci. 2007 Apr;52(4):983-7. doi: 10.1007/s10620-006-9156-7. Epub 2007 Mar 7.
5
Therapy of gastroesophageal reflux disease and functional dyspepsia overlaps with symptoms after usual-dose proton pump inhibitor: Acotiamide plus usual-dose proton pump inhibitor versus double-dose proton pump inhibitor.质子泵抑制剂常规剂量治疗胃食管反流病和功能性消化不良重叠：阿考替胺加质子泵抑制剂常规剂量与质子泵抑制剂双倍剂量。
J Gastroenterol Hepatol. 2018 Mar;33(3):623-630. doi: 10.1111/jgh.13970.
6
New Approaches to Diagnosis and Treatment of Functional Dyspepsia.功能性消化不良的诊断与治疗新方法
Curr Gastroenterol Rep. 2018 Oct 18;20(12):55. doi: 10.1007/s11894-018-0663-4.
7
Efficacy and safety of hangeshashinto for treatment of GERD refractory to proton pump inhibitors : Usual dose proton pump inhibitors plus hangeshashinto versus double-dose proton pump inhibitors: randomized, multicenter open label exploratory study.汉方治疗质子泵抑制剂难治性 GERD 的疗效和安全性：常规剂量质子泵抑制剂加汉方 versus 双倍剂量质子泵抑制剂：随机、多中心、开放标签探索性研究。
J Gastroenterol. 2019 Nov;54(11):972-983. doi: 10.1007/s00535-019-01588-4. Epub 2019 Apr 29.
8
[Role of acid in functional dyspepsia].[酸在功能性消化不良中的作用]
Nihon Rinsho. 2015 Jul;73(7):1202-8.
9
ACG and CAG Clinical Guideline: Management of Dyspepsia.ACG 和 CAG 临床指南：消化不良的管理。
Am J Gastroenterol. 2017 Jul;112(7):988-1013. doi: 10.1038/ajg.2017.154. Epub 2017 Jun 20.
10
Efficacy of acotiamide in combination with esomeprazole for functional dyspepsia refractory to proton-pump inhibitor monotherapy.阿考替胺联合埃索美拉唑治疗质子泵抑制剂单药治疗无效的功能性消化不良的疗效
Tohoku J Exp Med. 2014 Nov;234(3):237-40. doi: 10.1620/tjem.234.237.

引用本文的文献

1
Why think twice before prescribing proton pump inhibitors.在开质子泵抑制剂处方前为何要三思。
Eur J Pediatr. 2025 Mar 5;184(3):227. doi: 10.1007/s00431-025-06058-z.
2
British Society of Gastroenterology guidelines on the management of functional dyspepsia.英国胃肠病学会功能性消化不良管理指南。
Gut. 2022 Sep;71(9):1697-1723. doi: 10.1136/gutjnl-2022-327737. Epub 2022 Jul 7.

本文引用的文献

1
Detection of gastritis-associated pathogens by culturing of gastric juice and mucosa.通过胃液和黏膜培养检测胃炎相关病原体。
Int J Clin Exp Pathol. 2018 Apr 1;11(4):2214-2220. eCollection 2018.
2
Higher Levels of Streptococcus in Upper Gastrointestinal Mucosa Associated with Symptoms in Patients with Functional Dyspepsia.上消化道黏膜中链球菌水平升高与功能性消化不良患者的症状相关。
Digestion. 2020;101(1):38-45. doi: 10.1159/000504090. Epub 2019 Nov 21.
3
Gastric Microbiota in -Negative and -Positive Gastritis Among High Incidence of Gastric Cancer Area.
胃癌高发地区阴性和阳性胃炎中的胃微生物群
Cancers (Basel). 2019 Apr 10;11(4):504. doi: 10.3390/cancers11040504.
4
Proton-pumping F-ATPase plays an important role in Streptococcus mutans under acidic conditions.质子泵 F-ATP 酶在酸性条件下对变形链球菌起重要作用。
Arch Biochem Biophys. 2019 May 15;666:46-51. doi: 10.1016/j.abb.2019.03.014. Epub 2019 Mar 29.
5
DA-9701 (Motilitone): A Multi-Targeting Botanical Drug for the Treatment of Functional Dyspepsia.DA-9701（动力素）：一种用于治疗功能性消化不良的多靶点植物药。
Int J Mol Sci. 2018 Dec 13;19(12):4035. doi: 10.3390/ijms19124035.
6
Gut Microbiota Composition Before and After Use of Proton Pump Inhibitors.质子泵抑制剂使用前后的肠道微生物组成。
Dig Dis Sci. 2018 Nov;63(11):2940-2949. doi: 10.1007/s10620-018-5122-4. Epub 2018 May 24.
7
Oral microbiome alterations of healthy volunteers with proton pump inhibitor.质子泵抑制剂对健康志愿者口腔微生物组的影响。
J Gastroenterol Hepatol. 2018 May;33(5):1059-1066. doi: 10.1111/jgh.14040. Epub 2018 Feb 14.
8
Comparison of the human gastric microbiota in hypochlorhydric states arising as a result of Helicobacter pylori-induced atrophic gastritis, autoimmune atrophic gastritis and proton pump inhibitor use.幽门螺杆菌诱导的萎缩性胃炎、自身免疫性萎缩性胃炎及质子泵抑制剂使用导致的胃酸缺乏状态下人类胃微生物群的比较。
PLoS Pathog. 2017 Nov 2;13(11):e1006653. doi: 10.1371/journal.ppat.1006653. eCollection 2017 Nov.
9
Functional dyspepsia and gastroparesis.功能性消化不良和胃轻瘫。
Curr Opin Gastroenterol. 2017 Nov;33(6):446-454. doi: 10.1097/MOG.0000000000000393.
10
Functional dyspepsia is associated with duodenal eosinophilia in an Australian paediatric cohort.功能性消化不良与澳大利亚儿科队列中的十二指肠嗜酸性粒细胞增多有关。
Aliment Pharmacol Ther. 2017 May;45(10):1358-1364. doi: 10.1111/apt.14045. Epub 2017 Mar 21.